Presented at: AACR 2022
Development of specific multiplexed immunofluorescence immune assays to study mouse models of tumorigenesis
Register here for download
Relevant for
FixVUE, InSituPlex
Description Our poster describes the verification process to development specific pre-clinical mouse specific multiplexed immunofluorescence (mIF) assays. The use of pre-clinical mouse tumor models is widely used to demonstrate efficacy of novel immunotherapies, however a more comprehensive view of their tumor-immune compositions and their relevance to human tumors is needed. The use of specific mouse tissue phenotyping and mIF assays offer the unique advantage of preserving the architectural features of the tumor and revealing the spatial relationships between tumor cells and immune cells.
Authors
Yvette Cajigas, Alina Ainbinder, Gourab Chatterjee, Angela Vasaturo, Holger Weber, Erin Nicola, Mael Manesse, Kirsteen H. Maclean
Want to meet with us? Check out our upcoming events.
Related Content
Characterizing spatial distribution of immune-cell subsets in Nonalcoholic Steatohepatitis and Primary Sclerosing Cholangitis using a novel 12-plex Ultimapper ® kit
Presented at EASL 2021
Overview of the differences between standard IHC and multiplexed immunofluoresence
Ultivue
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Length: 60 minutes
